1
SPDR SER TR
S&P BIOTECH
XBI
XBI
570,000
$90.2m48.01%
48.01%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 284.9k, Q2 2026 570.0k
+285.1k
+285,100
100.1%
2
ISHARES TR
0-3 MNTH TREASRY
SGOV
SGOV
700,000
$70.5m37.51%
37.51%
Unchanged Shares held: Q3 2025 —, Q4 2025 700.0k, Q1 2026 700.0k, Q2 2026 700.0k
3
ROYALTY PHARMA PLC
SHS CLASS A
RPRX
RPRX
11,000
$616.8k0.33%
0.33%
Unchanged Shares held: Q3 2025 —, Q4 2025 13.8k, Q1 2026 11.0k, Q2 2026 11.0k
4
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
25,000
$606.5k0.32%
0.32%
Reduced Shares held: Q3 2025 —, Q4 2025 28.7k, Q1 2026 28.7k, Q2 2026 25.0k
-3.7k
-3,700
-12.9%
5
INCYTE CORP
COM
INCY
INCY
5,300
$600.8k0.32%
0.32%
Unchanged Shares held: Q3 2025 —, Q4 2025 5.3k, Q1 2026 5.3k, Q2 2026 5.3k
6
ARGENX SE
SPONSORED ADR
ARGX
ARGX
641
$594.7k0.32%
0.32%
Unchanged Shares held: Q3 2025 —, Q4 2025 630, Q1 2026 641, Q2 2026 641
7
DISC MEDICINE INC
COM
IRON
IRON
8,000
$585.1k0.31%
0.31%
Unchanged Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 8.0k, Q2 2026 8.0k
8
RAPPORT THERAPEUTICS INC
COM
RAPP
RAPP
14,000
$583.4k0.31%
0.31%
Unchanged Shares held: Q3 2025 —, Q4 2025 17.5k, Q1 2026 14.0k, Q2 2026 14.0k
9
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
17,000
$567.6k0.30%
0.30%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.1k, Q2 2026 17.0k
-5.1k
-5,100
-23.1%
10
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
30,000
$559.5k0.30%
0.30%
Unchanged Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.0k, Q2 2026 30.0k
11
MONTE ROSA THERAPEUTICS INC
COM
GLUE
GLUE
23,000
$556.6k0.30%
0.30%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 28.0k, Q2 2026 23.0k
-5.0k
-5,000
-17.9%
12
TG THERAPEUTICS INC
COM
TGTX
TGTX
10,000
$549.4k0.29%
0.29%
Reduced Shares held: Q3 2025 —, Q4 2025 17.8k, Q1 2026 13.0k, Q2 2026 10.0k
-3.0k
-3,000
-23.1%
13
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
7,000
$547.9k0.29%
0.29%
Reduced Shares held: Q3 2025 —, Q4 2025 8.0k, Q1 2026 8.0k, Q2 2026 7.0k
-1.0k
-1,026
-12.8%
14
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
6,800
$539.2k0.29%
0.29%
Unchanged Shares held: Q3 2025 —, Q4 2025 6.8k, Q1 2026 6.8k, Q2 2026 6.8k
15
PHARVARIS N V
COM
PHVS
PHVS
15,000
$518.7k0.28%
0.28%
Reduced Shares held: Q3 2025 —, Q4 2025 20.5k, Q1 2026 20.0k, Q2 2026 15.0k
-5.0k
-5,000
-25.0%
16
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
19,700
$516.5k0.27%
0.27%
Unchanged Shares held: Q3 2025 —, Q4 2025 18.7k, Q1 2026 19.7k, Q2 2026 19.7k
17
AURINIA PHARMACEUTICALS INC
COM
AUPH
AUPH
30,000
$509.1k0.27%
0.27%
Unchanged Shares held: Q3 2025 —, Q4 2025 34.0k, Q1 2026 30.0k, Q2 2026 30.0k
18
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
3,000
$505.6k0.27%
0.27%
Reduced Shares held: Q3 2025 —, Q4 2025 3.7k, Q1 2026 3.8k, Q2 2026 3.0k
-848
-848
-22.0%
19
IMMUNOVANT INC
COM
IMVT
IMVT
13,000
$500.9k0.27%
0.27%
Reduced Shares held: Q3 2025 —, Q4 2025 20.3k, Q1 2026 19.2k, Q2 2026 13.0k
-6.2k
-6,200
-32.3%
20
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
19,766
$500.1k0.27%
0.27%
Unchanged Shares held: Q3 2025 —, Q4 2025 19.8k, Q1 2026 19.8k, Q2 2026 19.8k
21
PTC THERAPEUTICS INC
COM
PTCT
PTCT
6,000
$489.4k0.26%
0.26%
Unchanged Shares held: Q3 2025 —, Q4 2025 7.0k, Q1 2026 6.0k, Q2 2026 6.0k
22
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
13,000
$483.7k0.26%
0.26%
Unchanged Shares held: Q3 2025 —, Q4 2025 20.4k, Q1 2026 13.0k, Q2 2026 13.0k
23
IMMUNOCORE HLDGS PLC
ADS
IMCR
IMCR
15,141
$480.7k0.26%
0.26%
Unchanged Shares held: Q3 2025 —, Q4 2025 14.4k, Q1 2026 15.1k, Q2 2026 15.1k
24
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
10,000
$470.4k0.25%
0.25%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 34.8k, Q2 2026 10.0k
-24.8k
-24,800
-71.3%
25
COGENT BIOSCIENCES INC
COM
COGT
COGT
12,000
$464.4k0.25%
0.25%
Unchanged Shares held: Q3 2025 —, Q4 2025 13.2k, Q1 2026 12.0k, Q2 2026 12.0k
26
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
4,000
$458.7k0.24%
0.24%
Reduced Shares held: Q3 2025 —, Q4 2025 6.3k, Q1 2026 6.3k, Q2 2026 4.0k
-2.3k
-2,300
-36.5%
27
DYNE THERAPEUTICS INC
COM
DYN
DYN
20,000
$444.2k0.24%
0.24%
Unchanged Shares held: Q3 2025 —, Q4 2025 21.5k, Q1 2026 20.0k, Q2 2026 20.0k
28
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
1,465
$441.0k0.23%
0.23%
Unchanged Shares held: Q3 2025 —, Q4 2025 1.3k, Q1 2026 1.5k, Q2 2026 1.5k
29
TARSUS PHARMACEUTICALS INC
COM
TARS
TARS
7,000
$440.6k0.23%
0.23%
Unchanged Shares held: Q3 2025 —, Q4 2025 6.5k, Q1 2026 7.0k, Q2 2026 7.0k
30
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
20,000
$437.2k0.23%
0.23%
Unchanged Shares held: Q3 2025 —, Q4 2025 24.7k, Q1 2026 20.0k, Q2 2026 20.0k
31
EXELIXIS INC
COM
EXEL
EXEL
8,000
$435.3k0.23%
0.23%
Reduced Shares held: Q3 2025 —, Q4 2025 11.9k, Q1 2026 11.9k, Q2 2026 8.0k
-3.9k
-3,948
-33.0%
32
CRINETICS PHARMACEUTICALS IN
COM
CRNX
CRNX
11,000
$411.6k0.22%
0.22%
Unchanged Shares held: Q3 2025 —, Q4 2025 11.3k, Q1 2026 11.0k, Q2 2026 11.0k
33
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
12,000
$406.7k0.22%
0.22%
Reduced Shares held: Q3 2025 —, Q4 2025 14.9k, Q1 2026 15.0k, Q2 2026 12.0k
-3.0k
-3,000
-20.0%
34
ASCENDIS PHARMA A/S
ORD SHS
ASND
ASND
1,500
$400.1k0.21%
0.21%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.5k
35
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
5,000
$398.6k0.21%
0.21%
New Shares held: Q3 2025 —, Q4 2025 15.5k, Q1 2026 0, Q2 2026 5.0k
36
STOKE THERAPEUTICS INC
COM
STOK
STOK
12,000
$392.6k0.21%
0.21%
Unchanged Shares held: Q3 2025 —, Q4 2025 16.6k, Q1 2026 12.0k, Q2 2026 12.0k
37
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
10,000
$390.1k0.21%
0.21%
Reduced Shares held: Q3 2025 —, Q4 2025 14.7k, Q1 2026 15.0k, Q2 2026 10.0k
-5.0k
-5,000
-33.3%
38
IMMUNOME INC
COM
IMNM
IMNM
18,000
$381.4k0.20%
0.20%
Reduced Shares held: Q3 2025 —, Q4 2025 25.2k, Q1 2026 20.0k, Q2 2026 18.0k
-2.0k
-2,000
-10.0%
39
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
3,000
$367.7k0.20%
0.20%
Unchanged Shares held: Q3 2025 —, Q4 2025 6.1k, Q1 2026 3.0k, Q2 2026 3.0k
40
HARMONY BIOSCIENCES HLDGS IN
COM
HRMY
HRMY
10,000
$364.1k0.19%
0.19%
Reduced Shares held: Q3 2025 —, Q4 2025 14.3k, Q1 2026 14.3k, Q2 2026 10.0k
-4.3k
-4,283
-30.0%
41
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
7,000
$355.2k0.19%
0.19%
Unchanged Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 7.0k, Q2 2026 7.0k
42
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
4,000
$355.1k0.19%
0.19%
Reduced Shares held: Q3 2025 —, Q4 2025 15.8k, Q1 2026 5.2k, Q2 2026 4.0k
-1.2k
-1,159
-22.5%
43
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
20,000
$338.4k0.18%
0.18%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 26.9k, Q2 2026 20.0k
-6.9k
-6,900
-25.6%
44
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
600
$322.2k0.17%
0.17%
Unchanged Shares held: Q3 2025 —, Q4 2025 892, Q1 2026 600, Q2 2026 600
45
KINIKSA PHARMACEUTICALS INTL
ORD SHS CL A
KNSA
KNSA
5,000
$319.8k0.17%
0.17%
Reduced Shares held: Q3 2025 —, Q4 2025 12.7k, Q1 2026 9.0k, Q2 2026 5.0k
-4.0k
-4,000
-44.4%
46
ALKERMES PLC
SHS
ALKS
ALKS
6,000
$314.4k0.17%
0.17%
Unchanged Shares held: Q3 2025 —, Q4 2025 19.3k, Q1 2026 6.0k, Q2 2026 6.0k
47
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
10,000
$312.6k0.17%
0.17%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 14.4k, Q2 2026 10.0k
-4.4k
-4,400
-30.6%
48
ARDELYX INC
COM
ARDX
ARDX
60,000
$306.0k0.16%
0.16%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 80.0k, Q2 2026 60.0k
-20.0k
-20,000
-25.0%
49
VERA THERAPEUTICS INC
CL A
VERA
VERA
7,000
$300.4k0.16%
0.16%
Reduced Shares held: Q3 2025 —, Q4 2025 10.0k, Q1 2026 10.0k, Q2 2026 7.0k
-3.0k
-3,000
-30.0%
50
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
2,500
$292.7k0.16%
0.16%
Reduced Shares held: Q3 2025 —, Q4 2025 6.9k, Q1 2026 5.0k, Q2 2026 2.5k
-2.5k
-2,500
-50.0%
51
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
3,000
$285.5k0.15%
0.15%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 5.0k, Q2 2026 3.0k
-2.0k
-1,968
-39.6%
52
SUPERNUS PHARMACEUTICALS INC
COM
SUPN
SUPN
6,000
$279.1k0.15%
0.15%
Unchanged Shares held: Q3 2025 —, Q4 2025 10.8k, Q1 2026 6.0k, Q2 2026 6.0k
53
CRISPR THERAPEUTICS AG
NAMEN AKT
CRSP
CRSP
5,000
$272.7k0.15%
0.15%
Reduced Shares held: Q3 2025 —, Q4 2025 9.6k, Q1 2026 9.5k, Q2 2026 5.0k
-4.5k
-4,500
-47.4%
54
ZYMEWORKS INC
COM
ZYME
ZYME
10,000
$261.4k0.14%
0.14%
Unchanged Shares held: Q3 2025 —, Q4 2025 20.3k, Q1 2026 10.0k, Q2 2026 10.0k
55
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
692
$257.2k0.14%
0.14%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 692
56
COMPASS PATHWAYS PLC
SPONSORED ADS
CMPS
CMPS
18,000
$254.7k0.14%
0.14%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 71.0k, Q2 2026 18.0k
-53.0k
-53,000
-74.7%
57
XENON PHARMACEUTICALS INC
COM
XENE
XENE
4,200
$253.5k0.13%
0.13%
Unchanged Shares held: Q3 2025 —, Q4 2025 11.7k, Q1 2026 4.2k, Q2 2026 4.2k
58
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
1,000
$244.8k0.13%
0.13%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.8k, Q2 2026 1.0k
-1.8k
-1,845
-64.8%
59
ARRIVENT BIOPHARMA INC
COM
AVBP
AVBP
7,041
$244.6k0.13%
0.13%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 7.0k
60
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
2,500
$243.7k0.13%
0.13%
Reduced Shares held: Q3 2025 —, Q4 2025 12.7k, Q1 2026 5.0k, Q2 2026 2.5k
-2.5k
-2,500
-50.0%
61
JAZZ PHARMACEUTICALS PLC
SHS USD
JAZZ
JAZZ
971
$234.0k0.12%
0.12%
New Shares held: Q3 2025 —, Q4 2025 3.3k, Q1 2026 0, Q2 2026 971
62
KODIAK SCIENCES INC
COM
KOD
KOD
6,000
$233.8k0.12%
0.12%
Reduced Shares held: Q3 2025 —, Q4 2025 19.4k, Q1 2026 10.0k, Q2 2026 6.0k
-4.0k
-4,000
-40.0%
63
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
1,200
$224.7k0.12%
0.12%
New Shares held: Q3 2025 —, Q4 2025 6.9k, Q1 2026 0, Q2 2026 1.2k
64
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
3,000
$223.4k0.12%
0.12%
Reduced Shares held: Q3 2025 —, Q4 2025 7.1k, Q1 2026 6.0k, Q2 2026 3.0k
-3.0k
-3,000
-50.0%
65
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
2,000
$222.1k0.12%
0.12%
New Shares held: Q3 2025 —, Q4 2025 4.7k, Q1 2026 0, Q2 2026 2.0k
66
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
8,463
$217.7k0.12%
0.12%
New Shares held: Q3 2025 —, Q4 2025 31.8k, Q1 2026 0, Q2 2026 8.5k
67
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
2,600
$211.9k0.11%
0.11%
New Shares held: Q3 2025 —, Q4 2025 6.7k, Q1 2026 0, Q2 2026 2.6k
68
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
3,827
$210.5k0.11%
0.11%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.8k
69
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
5,000
$203.2k0.11%
0.11%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 6.5k, Q2 2026 5.0k
-1.5k
-1,500
-23.1%
70
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
10,838
$194.7k0.10%
0.10%
Unchanged Shares held: Q3 2025 —, Q4 2025 44.2k, Q1 2026 10.8k, Q2 2026 10.8k
71
CYTOMX THERAPEUTICS INC
COM
CTMX
CTMX
39,400
$147.8k0.08%
0.08%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 39.4k
72
OCULAR THERAPEUTIX INC
COM
OCUL
OCUL
15,000
$147.3k0.08%
0.08%
Unchanged Shares held: Q3 2025 —, Q4 2025 42.9k, Q1 2026 15.0k, Q2 2026 15.0k
73
EYEPOINT PHARMACEUTICALS INC
COM NEW
EYPT
EYPT
10,000
$143.0k0.08%
0.08%
Unchanged Shares held: Q3 2025 —, Q4 2025 29.5k, Q1 2026 10.0k, Q2 2026 10.0k
74
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
13,000
$140.8k0.07%
0.07%
Unchanged Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.0k, Q2 2026 13.0k
75
OLEMA PHARMACEUTICALS INC
COM
OLMA
OLMA
10,000
$125.1k0.07%
0.07%
Unchanged Shares held: Q3 2025 —, Q4 2025 19.1k, Q1 2026 10.0k, Q2 2026 10.0k